SEC Form 4 · accession 0001162194-18-000110
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven McPhail
Officer — Chief Commercial Officer
Period of report
Nov 5, 2018
Accepted (ET)
Nov 7, 2018 · 6:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 5, 2018 | A | 16,344 | $6.29 | A | 53,229 | D | |
| Common StockF3 | Nov 5, 2018 | F | 4,894 | $7.40 | D | 48,335 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of Restricted Stock Units issued pursuant to the Issuer's 2011 Equity Incentive Plan in connection with the Issuer's cash retention bonus exchange program. Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. 100% of the Restricted Stock Units vested on November 5, 2018.
- F2Equal to 85% of the closing price of one share of Issuer's common stock on November 5, 2018.
- F3Equal to the closing price of one share of Issuer's common stock on November 5, 2018.